76 related articles for article (PubMed ID: 9081706)
1. In vitro targeting and specific transfection of human neuroblastoma cells by chCE7 antibody-mediated gene transfer.
Coll JL; Wagner E; Combaret V; Metchler K; Amstutz H; Iacono-Di-Cacito I; Simon N; Favrot MC
Gene Ther; 1997 Feb; 4(2):156-61. PubMed ID: 9081706
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of human neuroblastoma.
Prigione I; Corrias MV; Airoldi I; Raffaghello L; Morandi F; Bocca P; Cocco C; Ferrone S; Pistoia V
Ann N Y Acad Sci; 2004 Dec; 1028():69-80. PubMed ID: 15650233
[TBL] [Abstract][Full Text] [Related]
3. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma.
Jarnjak-Jankovic S; Pettersen RD; Saebøe-Larssen S; Wesenberg F; Olafsen MR; Gaudernack G
Cancer Gene Ther; 2005 Aug; 12(8):699-707. PubMed ID: 15846368
[TBL] [Abstract][Full Text] [Related]
5. Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene.
Corrias MV; Basso S; Meazza R; Musiani P; Santi L; Bocca P; Occhino M; Ferrini S; Pistoia V
Cancer Gene Ther; 1998; 5(1):38-44. PubMed ID: 9476965
[TBL] [Abstract][Full Text] [Related]
6. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB.
Yang X; Merchant MS; Romero ME; Tsokos M; Wexler LH; Kontny U; Mackall CL; Thiele CJ
Cancer Res; 2003 Mar; 63(5):1122-9. PubMed ID: 12615731
[TBL] [Abstract][Full Text] [Related]
7. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
8. Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody-based gene delivery system.
Mohr L; Schauer JI; Boutin RH; Moradpour D; Wands JR
Hepatology; 1999 Jan; 29(1):82-9. PubMed ID: 9862854
[TBL] [Abstract][Full Text] [Related]
9. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
[TBL] [Abstract][Full Text] [Related]
10. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes.
Sarkar AK; Nuchtern JG
Cancer Res; 2000 Apr; 60(7):1908-13. PubMed ID: 10766179
[TBL] [Abstract][Full Text] [Related]
11. Cellular processing of copper-67-labeled monoclonal antibody chCE7 by human neuroblastoma cells.
Novak-Hofer I; Amstutz HP; Mäcke HR; Schwarzbach R; Zimmermann K; Morgenthaler JJ; Schubiger PA
Cancer Res; 1995 Jan; 55(1):46-50. PubMed ID: 7805039
[TBL] [Abstract][Full Text] [Related]
12. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
13. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].
Zhang C; Tian Z; Hou G
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):369-72. PubMed ID: 11810763
[TBL] [Abstract][Full Text] [Related]
14. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated gene delivery for B-cell lymphoma in vitro.
Schachtschabel U; Pavlinkova G; Lou D; Köhler H
Cancer Gene Ther; 1996; 3(6):365-72. PubMed ID: 8988839
[TBL] [Abstract][Full Text] [Related]
16. CD80 transfected human hepatocellular carcinoma cells activate cytotoxic T lymphocytes to target HCC cells with shared tumor antigens.
Chan RC; Xie Y
Oncol Rep; 2004 Aug; 12(2):435-42. PubMed ID: 15254713
[TBL] [Abstract][Full Text] [Related]
17. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen.
David K; Ollert MW; Vollmert C; Heiligtag S; Eickhoff B; Erttmann R; Bredehorst R; Vogel CW
Cancer Res; 1999 Aug; 59(15):3768-75. PubMed ID: 10446994
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Jayaprabhu S; Pecorelli S; Parham GP; Cannon MJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):804s-810s. PubMed ID: 11300476
[TBL] [Abstract][Full Text] [Related]
19. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
20. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]